Gufic BioScience (GUFICBIO)

STALWART

FairStock Score: 7/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹296.5
Market Cap₹2,838.5 Cr
P/E Ratio56.74
ROCE13.15%
ROE8.8%
Dividend Yield0.04%
Profit Growth-35.68%
Debt/Equity0.58
Sales Growth11.37%
Promoter Holding72.5%
52-Week Range₹268 — ₹407.85
SectorPharmaceuticals & Biotechnology
Book Value₹58.2

Gufic BioScience trades with a P/E ratio of 56.74, ROCE of 13.15%, ROE of 8.8%, profit growth of -35.68%, debt-to-equity of 0.58. The FairStock Score of 7/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer